Aspirin low‑dose use for heart attack prevention debated in Spain
Low‑dose aspirin inhibits platelet aggregation, reducing the formation of clots that can block coronary or cerebral arteries. Because of this effect it is used to prevent a second myocardial infarction or stroke in patients who have already experienced a cardiovascular event.
The anti‑platelet action also increases the risk of bleeding, and the Spanish Society of Cardiology advises that routine aspirin use for primary prevention in people without known cardiovascular disease is not recommended, as the bleeding risk outweighs any benefit.
Aspirin was once a staple in Spanish households, but its use declined due to cost, ulcer risk and the association with Reye syndrome in children. It has largely been replaced by paracetamol and ibuprofen for general pain relief. Dr. Marcelo Sanmartín Fernández, a cardiologist at Hospital Universitario Ramón y Cajal, explains the drug’s properties and the current guidance.
Entities: Aspirin · Hospital Universitario Ramón y Cajal · Marcelo Sanmartín Fernández · Spain · Spanish Society of Cardiology
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 3 SOURCES] Dr. Marcelo Sanmartín Fernández is a cardiologist at Hospital Universitario Ramón y Cajal in Madrid.
- [● 3 SOURCES] Low‑dose aspirin inhibits platelet function, reducing clot formation in arteries. (Dr. Marcelo Sanmartín Fernández)
- [● 3 SOURCES] Paracetamol and ibuprofen have largely replaced aspirin for general pain relief in Spain.
- [● 3 SOURCES] Aspirin is recommended for secondary prevention in patients who have already suffered a cardiovascular event. (Dr. Marcelo Sanmartín Fernández)
- [● 3 SOURCES] Aspirin can cause bleeding because it prevents platelets from forming clots that stop bleeding. (Dr. Marcelo Sanmartín Fernández)
- [● 3 SOURCES] Aspirin usage in Spanish households declined due to cost, ulcer risk, and the association with Reye syndrome in children.
- [● 3 SOURCES] The Spanish Society of Cardiology advises against routine aspirin use for primary prevention in people without known cardiovascular disease. (Spanish Society of Cardiology)